EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"entry deregulation"
Narrow search

Narrow search

Year of publication
Subject
All
Bank competition 2 Entry deregulation 2 aggregate productivity 2 cost-sharing 2 entry deregulation 2 health insurance 2 pharmaceutical innovation 2 Forschungsfinanzierung 1 Gesetzliche Krankenversicherung 1 Gesundheitsökonomik 1 Kostenbeteiligung 1 Markteintritt 1 Neue Wachstumstheorie 1 Pharmazeutische Forschung 1 Produktivität 1 Theorie 1
more ... less ...
Online availability
All
Free 4
Type of publication
All
Book / Working Paper 4
Type of publication (narrower categories)
All
Working Paper 2
Language
All
English 3 Undetermined 1
Author
All
Grossmann, Volker 2 Kaas, Leo 2
Institution
All
CESifo 1 European Central Bank 1
Published in...
All
CESifo Working Paper 1 CESifo Working Paper Series 1 ECB Working Paper 1 Working Paper Series / European Central Bank 1
Source
All
EconStor 2 RePEc 2
Showing 1 - 4 of 4
Cover Image
Do cost-sharing and entry deregulation curb pharmaceutical Innovation?
Grossmann, Volker - 2011
coinsurance rate and stricter price regulations adversely affect R&D spending in the pharmaceutical sector. In contrast, entry … deregulation may lead to quality-improvements of pharmaceuticals, despite reducing price-setting power of pharmaceutical companies …
Persistent link: https://www.econbiz.de/10010275019
Saved in:
Cover Image
Do Cost-sharing and Entry Deregulation Curb Pharmaceutical Innovation?
Grossmann, Volker - CESifo - 2011
coinsurance rate and stricter price regulations adversely affect R&D spending in the pharmaceutical sector. In contrast, entry … deregulation may lead to quality-improvements of pharmaceuticals, despite reducing price-setting power of pharmaceutical companies …
Persistent link: https://www.econbiz.de/10009020095
Saved in:
Cover Image
Financial market integration and loan competition: when is entry deregulation socially beneficial?
Kaas, Leo - 2004
The paper analyzes how the removal of barriers to entry in banking affect loan competition, bank stability and economic welfare. We consider a model of spatial loan competition where a market that is served by less efficient banks is opened to entry by banks that are more efficient in screening...
Persistent link: https://www.econbiz.de/10011604449
Saved in:
Cover Image
Financial market integration and loan competition: when is entry deregulation socially beneficial?
Kaas, Leo - European Central Bank - 2004
The paper analyzes how the removal of barriers to entry in banking affect loan competition, bank stability and economic welfare. We consider a model of spatial loan competition where a market that is served by less efficient banks is opened to entry by banks that are more efficient in screening...
Persistent link: https://www.econbiz.de/10005530741
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...